MedPath

Pemetrexed

These highlights do not include all the information needed to use PEMETREXED FOR INJECTION safely and effectively. See full prescribing information for PEMETREXED FOR INJECTION. PEMETREXED for injection, for intravenous use Initial U.S. Approval: 2004

Approved
Approval ID

46a9b89d-7135-4e0c-b8e4-52580554769b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 13, 2021

Manufacturers
FDA

Qilu Pharmaceutical Co., Ltd.

DUNS: 653878256

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pemetrexed disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67184-0504
Application NumberANDA204890
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pemetrexed disodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 1, 2022
FDA Product Classification

INGREDIENTS (4)

MannitolInactive
Quantity: 500 mg in 20 mL
Code: 3OWL53L36A
Classification: IACT
Hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
Sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
PEMETREXED DISODIUM HEMIPENTAHYDRATEActive
Quantity: 500 mg in 20 mL
Code: F4GSH45R4C
Classification: ACTIM

Pemetrexed disodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67184-0503
Application NumberANDA204890
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pemetrexed disodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 1, 2022
FDA Product Classification

INGREDIENTS (4)

Hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
Sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
MannitolInactive
Quantity: 106 mg in 4 mL
Code: 3OWL53L36A
Classification: IACT
PEMETREXED DISODIUM HEMIPENTAHYDRATEActive
Quantity: 100 mg in 4 mL
Code: F4GSH45R4C
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pemetrexed - FDA Drug Approval Details